Search

everythinglearnresearchcommunity

for

Search:↓

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Targeting the AhR pathway may help treat alopecia areata.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Paroxetine relieves pain by increasing allopregnanolone levels.

Sandalore® improves hair growth and quality in people with hair loss.

Finasteride reduces pain in male rats and works better with testosterone.

Carvacrol activates the TRPV3 channel, which may help design new skin treatments.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.